Reforming Medicare payments for Part B drugs
Joseph Antos and
Additional contact information
James Capretta: American Enterprise Institute
AEI Economic Perspectives, 2019
The Trump administration has proposed a test of a new Medicare Part B payment system for drugs administered in physician offices and hospital outpatient clinics. The effect of this policy is an arbitrary payment cut. Joseph Antos and James C. Capretta propose an alternative market-based approach.
Keywords: Medicare; pharmaceuticals; AEI Economic Perspectives (search for similar items in EconPapers)
JEL-codes: A (search for similar items in EconPapers)
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://www.aei.org/wp-content/uploads/2019/06/Ref ... t-B-Drugs.pdf?x91208 (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:aei:journl:y:2019:id:1018985
Access Statistics for this article
More articles in AEI Economic Perspectives from American Enterprise Institute Contact information at EDIRC.
Bibliographic data for series maintained by Dave Adams, CIO ().